April 16, 2025 Nvidia’s $5.5B AI Chip Crunch and ASML’s Tariff Jitters
Amazon: Strategic Growth Opportunities Signal a Strong Buy
Nvidia: Evaluating Risks Amid Skyrocketing Valuation
March 12, 2025 Features of exchanging USDC ERC20 to Bank Transfer
February 19, 2025 Why Stock Caps Matter When Building a Diversified Portfolio
February 5, 2025 Top 5 Coins for the Maximum Passive Income from Staking by 2024
January 21, 2025 Trading Stocks With AI: A Modern Approach
January 21, 2025 Bitcoin Is Great, but Here Are 3 Altcoins Worth Considering in 2025
Alnylam Pharmaceuticals (ALNY) Stock Forecast for 2025, 2026, 2027. Sell or Buy?
Updated: April 20, 2025 (10:21)
Sector: HealthcareThe share price of Alnylam Pharmaceuticals, Inc. (ALNY) now
Are you interested in Alnylam Pharmaceuticals, Inc. stocks and want to buy them, or are they already in your portfolio? If yes, then on this page you will find useful information about the dynamics of the Alnylam Pharmaceuticals stock price in 2025, 2026, 2027. How much will one Alnylam Pharmaceuticals share be worth in 2025 - 2027?
When should I take profit in Alnylam Pharmaceuticals stock? When should I record a loss on Alnylam Pharmaceuticals stock? What are analysts' forecasts for Alnylam Pharmaceuticals stock? What is the future of Alnylam Pharmaceuticals stock? We forecast Alnylam Pharmaceuticals stock performance using neural networks based on historical data on Alnylam Pharmaceuticals stocks. Also, when forecasting, technical analysis tools are used, world geopolitical and news factors are taken into account.
Alnylam Pharmaceuticals stock prediction results are shown below and presented in the form of graphs, tables and text information, divided into time intervals. (Next month, 2025, 2026, 2027, and ) The final quotes of the instrument at the close of the previous trading day are a signal to adjust the forecasts for Alnylam Pharmaceuticals shares. This happens once a day.
Historical and forecast chart of Alnylam Pharmaceuticals stock
The chart below shows the historical price of Alnylam Pharmaceuticals stock and a prediction chart for the next month.
For convenience, prices are divided by color. Forecast prices include: Optimistic Forecast, Pessimistic Forecast,
and Weighted Average Best Forecast. Detailed values for the Alnylam Pharmaceuticals stock price can be found in the table below.
Long-term forecasts by years.
Alnylam Pharmaceuticals, Inc., a biopharmaceutical company, is engaged in the discovery, development and commercialization of RNA interference (RNAi) therapeutics. The company’s line of investigated RNAi therapies focuses on genetic drugs, cardiovascular diseases, liver infections, and central nervous system (CNS) / eye diseases.
Alnylam Pharmaceuticals daily forecast for a month
| Date | Target | Pes. | Opt. | Vol., % |
|---|---|---|---|---|
| Apr 22 | 242.94 | 238.05 | 248.11 | 4.22 |
| Apr 23 | 244.61 | 241.31 | 250.12 | 3.65 |
| Apr 24 | 246.45 | 242.31 | 250.66 | 3.45 |
| Apr 25 | 246.97 | 243.26 | 249.26 | 2.47 |
| Apr 26 | 243.41 | 238.15 | 248.81 | 4.48 |
| Apr 27 | 244.43 | 238.71 | 250.00 | 4.73 |
| Apr 28 | 241.06 | 238.82 | 243.30 | 1.88 |
| Apr 29 | 240.77 | 238.89 | 243.87 | 2.09 |
| Apr 30 | 237.88 | 234.81 | 240.73 | 2.52 |
| May 01 | 237.95 | 236.52 | 239.95 | 1.45 |
| May 02 | 236.81 | 233.83 | 241.14 | 3.13 |
| May 03 | 240.22 | 237.84 | 244.90 | 2.97 |
| May 04 | 244.11 | 240.52 | 249.53 | 3.74 |
| May 05 | 250.99 | 247.83 | 255.44 | 3.07 |
| May 06 | 250.84 | 247.98 | 255.96 | 3.22 |
| May 07 | 256.79 | 254.25 | 262.64 | 3.30 |
| May 08 | 261.33 | 256.94 | 263.84 | 2.69 |
| May 09 | 265.96 | 261.49 | 269.23 | 2.96 |
| May 10 | 268.51 | 262.23 | 274.80 | 4.79 |
| May 11 | 271.98 | 268.71 | 275.57 | 2.55 |
| May 12 | 268.22 | 262.35 | 271.76 | 3.59 |
| May 13 | 260.58 | 255.73 | 266.29 | 4.13 |
| May 14 | 267.07 | 261.54 | 273.00 | 4.38 |
| May 15 | 273.40 | 269.38 | 279.30 | 3.68 |
| May 16 | 272.33 | 268.82 | 276.01 | 2.67 |
| May 17 | 277.56 | 274.40 | 280.39 | 2.18 |
| May 18 | 271.15 | 265.94 | 277.41 | 4.31 |
| May 19 | 267.08 | 262.67 | 272.53 | 3.75 |
| May 20 | 269.97 | 266.00 | 275.88 | 3.71 |
| May 21 | 269.40 | 267.30 | 273.36 | 2.27 |
Alnylam Pharmaceuticals Daily Price Targets
Alnylam Pharmaceuticals Stock Forecast 04-22-2025.
Forecast target price for 04-22-2025: $242.94.
Positive dynamics for Alnylam Pharmaceuticals shares will prevail with possible volatility of 4.053%.
Pessimistic target level: 238.05
Optimistic target level: 248.11
Alnylam Pharmaceuticals Stock Forecast 04-23-2025.
Forecast target price for 04-23-2025: $244.61.
Positive dynamics for Alnylam Pharmaceuticals shares will prevail with possible volatility of 3.521%.
Pessimistic target level: 241.31
Optimistic target level: 250.12
Alnylam Pharmaceuticals Stock Forecast 04-24-2025.
Forecast target price for 04-24-2025: $246.45.
Positive dynamics for Alnylam Pharmaceuticals shares will prevail with possible volatility of 3.333%.
Pessimistic target level: 242.31
Optimistic target level: 250.66
Alnylam Pharmaceuticals Stock Forecast 04-25-2025.
Forecast target price for 04-25-2025: $246.97.
Positive dynamics for Alnylam Pharmaceuticals shares will prevail with possible volatility of 2.408%.
Pessimistic target level: 243.26
Optimistic target level: 249.26
Alnylam Pharmaceuticals Stock Forecast 04-26-2025.
Forecast target price for 04-26-2025: $243.41.
Negative dynamics for Alnylam Pharmaceuticals shares will prevail with possible volatility of 4.285%.
Pessimistic target level: 238.15
Optimistic target level: 248.81
Alnylam Pharmaceuticals Stock Forecast 04-27-2025.
Forecast target price for 04-27-2025: $244.43.
Positive dynamics for Alnylam Pharmaceuticals shares will prevail with possible volatility of 4.517%.
Pessimistic target level: 238.71
Optimistic target level: 250.00
ALNY (ALNY) Monthly Stock Prediction for 2025
| Month | Target | Pes. | Opt. | Vol., % |
|---|---|---|---|---|
| May. | 276.43 | 232.31 | 315.90 | 26.46 |
| Jun. | 278.17 | 259.48 | 321.98 | 19.41 |
| Jul. | 282.84 | 243.05 | 300.07 | 19.00 |
| Aug. | 270.96 | 247.07 | 295.43 | 16.37 |
| Sep. | 251.62 | 239.46 | 288.61 | 17.03 |
| Oct. | 269.06 | 243.63 | 295.05 | 17.43 |
| Nov. | 306.91 | 285.64 | 352.03 | 18.86 |
| Dec. | 320.45 | 279.40 | 346.02 | 19.25 |
Alnylam Pharmaceuticals forecast for this year
Alnylam Pharmaceuticals Stock Prediction for May 2025
An uptrend is forecast for this month with an optimal target price of $276.429. Pessimistic: $232.31. Optimistic: $315.90
Alnylam Pharmaceuticals Stock Prediction for Jun 2025
An uptrend is forecast for this month with an optimal target price of $278.17. Pessimistic: $259.48. Optimistic: $321.98
Alnylam Pharmaceuticals Stock Prediction for Jul 2025
An uptrend is forecast for this month with an optimal target price of $282.844. Pessimistic: $243.05. Optimistic: $300.07
Alnylam Pharmaceuticals Stock Prediction for Aug 2025
An downtrend is forecast for this month with an optimal target price of $270.964. Pessimistic: $247.07. Optimistic: $295.43
Alnylam Pharmaceuticals Stock Prediction for Sep 2025
An downtrend is forecast for this month with an optimal target price of $251.617. Pessimistic: $239.46. Optimistic: $288.61
Alnylam Pharmaceuticals Stock Prediction for Oct 2025
An uptrend is forecast for this month with an optimal target price of $269.055. Pessimistic: $243.63. Optimistic: $295.05
Alnylam Pharmaceuticals Stock Prediction for Nov 2025
An uptrend is forecast for this month with an optimal target price of $306.91. Pessimistic: $285.64. Optimistic: $352.03
Alnylam Pharmaceuticals Stock Prediction for Dec 2025
An uptrend is forecast for this month with an optimal target price of $320.445. Pessimistic: $279.40. Optimistic: $346.02
Alnylam Pharmaceuticals (ALNY) Monthly Stock Prediction for 2026
| Month | Target | Pes. | Opt. | Vol., % |
|---|---|---|---|---|
| Jan | 294.20 | 260.22 | 315.21 | 17.44 |
| Feb | 335.60 | 280.62 | 360.26 | 22.11 |
| Mar | 305.29 | 254.00 | 326.45 | 22.19 |
| Apr | 313.63 | 279.38 | 333.38 | 16.20 |
| May | 351.83 | 292.72 | 407.24 | 28.12 |
| Jun | 320.79 | 289.81 | 371.32 | 21.95 |
| Jul | 347.07 | 310.63 | 403.92 | 23.10 |
| Aug | 382.05 | 322.68 | 403.71 | 20.07 |
| Sep | 406.12 | 344.72 | 464.11 | 25.73 |
| Oct | 397.59 | 377.55 | 442.68 | 14.71 |
| Nov | 444.35 | 413.56 | 512.47 | 19.30 |
| Dec | 431.29 | 377.85 | 470.23 | 19.65 |
Alnylam Pharmaceuticals (ALNY) Monthly Stock Prediction for 2027
| Month | Target | Pes. | Opt. | Vol., % |
|---|---|---|---|---|
| Jan | 383.28 | 343.04 | 404.21 | 15.13 |
| Feb | 405.82 | 387.07 | 424.57 | 8.83 |
| Mar | 360.65 | 310.67 | 419.73 | 25.98 |
| Apr | 422.00 | 379.46 | 458.33 | 17.21 |
| May | 465.42 | 433.17 | 526.02 | 17.65 |
| Jun | 512.34 | 447.78 | 588.73 | 23.94 |
| Jul | 559.68 | 529.12 | 621.97 | 14.93 |
| Aug | 613.74 | 531.26 | 645.96 | 17.76 |
| Sep | 568.63 | 496.98 | 648.64 | 23.38 |
| Oct | 563.86 | 501.10 | 630.17 | 20.48 |
| Nov | 478.60 | 439.40 | 504.73 | 12.94 |
| Dec | 476.59 | 425.55 | 499.61 | 14.82 |
Alnylam Pharmaceuticals information and performance
675 WEST KENDALL STREET, HENRI A. TERMEER SQUARE, CAMBRIDGE, MA, US
Market capitalization of the Alnylam Pharmaceuticals, Inc. is the total market value of all issued shares of a company. It is calculated by the formula multiplying the number of ALNY shares in the company outstanding by the market price of one share.
EBITDA of Alnylam Pharmaceuticals is earnings before interest, income tax and depreciation of assets.
P/E ratio (price to earnings) - shows the ratio between the price of a share and the company's profit
Price/earnings to growth
Dividend Per Share is a financial indicator equal to the ratio of the company's net profit available for distribution to the annual average of ordinary shares.
Dividend yield is a ratio that shows how much a company pays in dividends each year at the stock price.
EPS shows how much of the net profit is accounted for by the common share.
Trailing P/E depends on what has already been done. It uses the current share price and divides it by the total earnings per share for the last 12 months.
Forward P/E uses projections of future earnings instead of final numbers.
Enterprise Value (EV) /Revenue
The EV / EBITDA ratio shows the ratio of the cost (EV) to its profit before tax, interest and amortization (EBITDA).
Number of issued ordinary shares
Number of freely tradable shares
Shares Short Prior Month - the number of shares in short positions in the last month.
FAQ (Frequently Asked Questions about Alnylam Pharmaceuticals Stock)
Should I Buy Alnylam Pharmaceuticals Shares in 2025 year?
Does Alnylam Pharmaceuticals pay dividends?
Which economic sector do Alnylam Pharmaceuticals's shares belong to?
Which other securities belong to the same sector as Alnylam Pharmaceuticals's shares?
